COVID-19 Pandemic Impact on Chronic Lymphocytic Leukemia (CLL) Patients' Preferences Towards Therapies: The Italian Experience (CHOICE Study)

Introduction: All the available CLL therapies differ for relevant aspects as duration of response, mode of administration, treatment duration and adverse events: the CHOICE study was designed to investigate CLL patients' Quality of Life (QoL) and preferences towards different treatment attribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Molica, Stefano, Laurenti, Luca, Ghia, Paolo, Coscia, Marta, Cuneo, Antonio, Gaidano, Gianluca, Mauro, Francesca, Frustaci, Anna Maria, Vallisa, Daniele, Pane, Fabrizio, Gualberti, Giuliana, Iannella, Emilia, Finsinger, Paola, Caira, Morena, Sportoletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
642.Chronic Lymphocytic Leukemia: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701542/
http://dx.doi.org/10.1182/blood-2021-148308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701542/
http://dx.doi.org/10.1182/blood-2021-148308

Ejemplares similares